Skip to main content
PharmGen Science, Inc. logo

PharmGen Science, Inc. — Investor Relations & Filings

Ticker · 004720 ISIN · KR7004720009 KO Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2020-03-10 Proxy Solicitation & In…
Country KR South Korea
Listing KO 004720

About PharmGen Science, Inc.

http://www.pharmgenscience.com/en/

PharmGen Science, Inc. is a pharmaceutical company engaged in the research, development, production, and sale of medicaments. The company's portfolio encompasses a range of prescription (ETC) and over-the-counter (OTC) drugs, including analgesics, antibiotics, and anti-inflammatory agents. A key strategic focus for the company is the discovery and development of novel drugs for gastrointestinal (GI) disorders. PharmGen Science aims to provide integrated pharmaceutical solutions by leveraging its diverse infrastructure and global network.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Wooridul Pharmaceutical Co., Ltd. It contains the meeting agenda, details on voting procedures (including electronic voting), and management's report on business operations and financial statements (including balance sheets, income statements, and capital change tables). This document is a formal proxy statement and meeting notice sent to shareholders to solicit votes and provide information for the upcoming AGM. In the context of the provided categories, this fits best as a Proxy Solicitation & Information Statement (PSI).
2020-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Reference Document' (참고서류) for a General Meeting of Shareholders (주주총회), specifically for Woori-dle Pharmaceutical's 54th Annual General Meeting. It includes details on the meeting date, agenda items, and financial statements (balance sheet, income statement, etc.). According to the provided definitions, documents sent to shareholders to provide information and request votes for meetings are classified as Proxy Solicitation & Information Statements (PSI).
2020-03-10 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Woori-dle Pharmaceutical. It outlines the date, location, and specific agenda items for the upcoming meeting, including the approval of financial statements, election of directors, and remuneration limits. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and agenda items, which falls under the PSI category.
2020-03-09 Korean
주주총회집중일개최사유신고
Regulatory Filings Classification · 95% confidence The document is a formal notification filed by 'Woori-dle Pharmaceutical' regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the reasons for this scheduling conflict and provides the meeting date and notice date. Since this is a regulatory notification regarding the logistics of a shareholder meeting rather than the meeting materials themselves or the results, it falls under the general regulatory filing category.
2020-03-09 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (Woori-deul Pharmaceutical) announcing a significant change in sales or profit structure (30% or more). This is a standard preliminary earnings disclosure required by the Korea Exchange (KRX) before the final audited financial statements are released. It provides key financial highlights (revenue, operating profit, net income) and explicitly states it is based on unaudited preliminary data. This fits the definition of an Earnings Release (ER) as it is an initial announcement of periodical financial results.
2020-02-12 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled 'Report on the Appointment, Dismissal, or Resignation of Outside Directors' (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). It details the resignation of an outside director for personal reasons. This falls under the category of Board/Management Information, as it concerns changes to the composition of the board of directors.
2020-01-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.